Audiological Outcomes of Cytomegalovirus Saliva PCR‐Positive Newborns in Support of Universal Screening
Otolaryngology–Head and Neck Surgery · 2025
DOI: 10.1002/ohn.1332 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2025. Verfasst von Celine Richard und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head & Neck Surgery, University of Tennessee Health Science Center, Memphis, Tennessee, USA. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Saliva, Neonatal Screening, Hearing Loss, Sensorineural. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben.
Abstract (Originalsprache)
Objective
This study aims to describe the audiological outcomes of cytomegalovirus (CMV)‐positive newborns detected through universal screening. Study Design Retrospective cohort.
Setting
Three nurseries and a neonatal intensive care unit in Memphis, Tennessee.
Methods
Data were analyzed from patients screened for congenital CMV (cCMV) by saliva polymerase chain reaction from March 2016 to May 2024. Newborns were classified based on symptoms at birth.
Results
Among 247 CMV‐positive newborns (134 males, 54.2%), 77 (31.17%) were symptomatic. Among these, 16 were diagnosed with sensorineural hearing loss (SNHL): 12 bilateral SNHL (BHL), 4 with unilateral SNHL (UNHL). Three symptomatic patients developed late‐onset UNHL. Four of the asymptomatic newborns developed UNHL, and one BHL, within the first year of life. Fifty‐eight patients received valganciclovir. Among the patients who eventually developed SNHL, 5/10 treated experienced worsening or lack of improvement; 10/14 untreated cases showed hearing deterioration or did not improve, and 2/14 remained stable. Patients with SNHL had higher rates of microcephaly and intracranial calcifications compared to those with normal hearing but showed no differences in urine CMV viral load at birth. In the current cohort, nine patients have cochlear implants (seven bilateral, one unilateral) and four have hearing aids (three bilateral, one unilateral). Social vulnerability was associated with fewer follow‐ups in patients with SNHL.
Conclusion
This study underscores the profound impact of cCMV infection on hearing outcomes, even when asymptomatic at birth. It reinforces the importance of universal cCMV screening programs to identify infants at risk for SNHL. It also highlights the impact of social determinants of health on long‐term follow‐up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head & Neck Surgery, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
- Division of Pediatric Otolaryngology, Le Bonheur Children's Hospital, Memphis, Tennessee, USA.
- Division of Infectious Diseases, Le Bonheur Children's Hospital, Memphis, Tennessee, USA.
- Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
- Department of Pediatrics, University of Tennessee Health Science Center, Division of Infectious Diseases, Memphis, Tennessee, USA.
ORCID-Profile: Celine Richard, Leyn Shakhtour, Nina Gallo, Sandra R Arnold, Maria A Carrillo-Marquez
Zitieren
APA
Richard, C., Shakhtour, L., Gallo, N., Smith, R., MacDonald, C. B., Gentry, R., Scheerer, H., Arnold, S. R., & Carrillo-Marquez, M. A. (2025). Audiological Outcomes of Cytomegalovirus Saliva PCR‐Positive Newborns in Support of Universal Screening. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.1332
Vancouver
Richard C, Shakhtour L, Gallo N, Smith R, MacDonald CB, Gentry R, et al. Audiological Outcomes of Cytomegalovirus Saliva PCR‐Positive Newborns in Support of Universal Screening. Otolaryngology–Head and Neck Surgery. 2025. doi:10.1002/ohn.1332
BibTeX
@article{Richard2025,
author = {Richard, Celine and Shakhtour, Leyn and Gallo, Nina and Smith, Rebecca and MacDonald, Charles B and Gentry, Ramona and Scheerer, Hayley and Arnold, Sandra R and Carrillo-Marquez, Maria A},
title = {Audiological Outcomes of Cytomegalovirus Saliva PCR‐Positive Newborns in Support of Universal Screening},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2025},
doi = {10.1002/ohn.1332}
}
EUVIMED